This inventor holds 5 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Cell2in, Inc., Korea University Research and Business Foundation, Snu Rdb Foundation. Active years: 2019-2023.
Location History:
- Gyeonggi-do, KR (2019 - 2020)
- Seoul, KR (2022 - 2023)
Company Filing History:
5 out of 5 
2 out of 1,262 
2 out of 549 
Years Active: 2019-2023
Title: Heun Soo Kang: Innovator in Therapeutic Cell Quality Improvement
Introduction
Heun Soo Kang is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of therapeutic cell quality improvement, holding a total of 5 patents. His work focuses on innovative methods that enhance the quality of therapeutic cells through advanced monitoring techniques.
Latest Patents
Among his latest patents, Heun Soo Kang has developed a method for improving the quality of therapeutic cells through real-time glutathione measurement. This invention relates to a technique that allows for the monitoring of glutathione levels in therapeutic cells, thereby ensuring their quality. Additionally, he has created a method for measuring the quality of therapeutic cells through real-time glutathione monitoring, which provides a reliable way to assess cell quality during therapeutic applications.
Career Highlights
Heun Soo Kang has worked with several companies throughout his career, including Cell2in, Inc. and Snur & Db Foundation. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in therapeutic cell technologies.
Collaborations
He has collaborated with notable coworkers such as Ki Hang Choi and Hye Mi Kim, further enhancing the impact of his work in the field.
Conclusion
Heun Soo Kang's contributions to the field of therapeutic cell quality improvement are significant and impactful. His innovative methods and collaborations continue to advance the understanding and application of therapeutic cells in medical science.